ArticleCancers2022
Targeting High-Risk Neuroblastoma Patient-Derived Xenografts with Oncolytic Virotherapy.
Colin H Quinn et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papercites it
ArticleCancers2022
Colin H Quinn et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.